Parker Waichman LLP

Complications, Deaths Seen with Some Long-Acting Asthma Drugs

Some asthma drugs in a class  known as long-acting beta agonists (LABA) can increase the risk of death and complications, a new Food & Drug Administration (FDA) analysis has found.  The analysis looked at GlaxoSmithKline PLC’s Serevent and Advair, Novartis AG’s and Schering-Plough Corp.’s Foradil and AstraZeneca PLC’s Symbicort. The FDA analysis was prepared for […]

Some asthma drugs in a class  known as long-acting beta agonists (LABA) can increase the risk of death and complications, a new Food & Drug Administration (FDA) analysis has found.  The analysis looked at GlaxoSmithKline PLC’s <"https://www.yourlawyer.com/topics/overview/serevent">Serevent and <"https://www.yourlawyer.com/topics/overview/advair">Advair, Novartis AG’s and Schering-Plough Corp.’s <"https://www.yourlawyer.com/topics/overview/Foradil">Foradil and AstraZeneca PLC’s Symbicort.

The FDA analysis was prepared for an advisory committee meeting next week that is slated to discuss the safety of the drugs, The Wall Street Journal said.  At the meeting, FDA advisors will consider whether LABAs should continue to be marketed for children and adults.

LABAs  prevent the release of substances in the body that cause inflammation of airways in the lungs. In 2005, the FDA strengthened the warning labels for the asthma drugs to state that they should be reserved for patients who did not respond to other asthma therapies.  The label changes came after a study found that patients taking Serevent where four times more likely to suffer an asthma-related death.  Others showed that Serevent and Foradil increased asthma exacerbations and hospitalizations in both adults and children.

According to Reuters, the FDA’s latest analysis found 2.8 more serious asthma events for every 1,000 asthma patients treated with a LABA. Children ages 4 to 11 “appeared to be at the greatest risk,” FDA statisticians said. The risk is lower when the drugs are used together with a steroid to treat underlying inflammation deep inside the airways, Reuters said.

According to The Wall Street Journal, the analysis involved 110 trials and 60,954 patients. The bulk of the patients were from Serevent trials, with about 43,000 patients, the FDA said. The agency said there were 20 asthma-related deaths in the studies and of those, 16 were patients on Serevent and four were patients in the non-LABA group.

The analysis found that only one of the drugs, Advair – which combines an LABA and a steroid in one inhaler – does not appear to increase the risk of a serious event or death, the Journal said.  However, Serevent had a significantly higher rate of serious complications than the others.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I had a friend who recommended Parker Waichman and I have to say I am so thankful that he suggested them. I found them to be very professional. Whenever I had an issue, I always spoke to Tina Morace. She was always prompt in returning my calls, and never to busy to answer any of my questions. She played an integral part in making the whole process stress free for me. Tina and the firm never kept me in the dark on what was going on. I will definitely use them again, and I highly recommend them.
Walter Sherrod
4 months ago
5 Star Reviews 150
I highly recommend this law firm for their excellent work on my case. Tina went above and beyond to ensure a successful outcome. Her dedication and hard work were evident throughout the entire process. She was always available to answer my questions and provided clear communication every step of the way. The firm as a whole was professional, knowledgeable, and provided exceptional service. I am grateful for their expertise and highly recommend them to anyone in need of legal assistance.
Danny Mulholland
9 months ago
5 Star Reviews 150
Thank you Parker Waichman LLP and Ms. Josephine Burgess-Zephrine's, for helping me with my case, still on going, but they are the best firm.
Thereesa “Cookiez” Collins
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038